Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EEC for Diagnosis of Tuberculosis Infection
NCT07152639Phase 3Recruiting
- Sponsor
- Chengdu Coen Biotechnology
- Start
- Aug 2025
- Primary completion
- May 2026
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of C-Tb in Tuberculosis (TB), sponsored by Chengdu Coen Biotechnology. Started Aug 2025; status: recruiting.
02
Drugs
C-Tb
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT07152639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07152639.